Increased advanced glycation end products in atherosclerotic lesions of patients with end-stage renal disease

Atherosclerosis

Volumn 142, Issue 1, 1999, Pages 67-77

  Sakata, Noriyuki ^a   Imanaga, Yoshinobu ^a   Meng, Jing ^a   Tachikawa, Yutaka ^a   Takebayashi, Shigeo ^a   Nagai, Ryoji ^b   Horiuchi, Seikoh ^b  

^a FUKUOKA UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Apolipoprotein B; Atherogenesis; End stage renal disease; Immunohistochemistry; Morphometry

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLYCATION; HEMODIALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE; MALE; MORPHOMETRICS; PRIORITY JOURNAL;

AGED; AORTA; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; DIABETIC NEPHROPATHIES; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY FAILURE, CHRONIC; LYSINE; MALE; MIDDLE AGED;

EID: 0032889858     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00192-0     Document Type: Article

References (27)

1. Lindner A., Charra B., Sherrard D.J., Scribner B.H. Accelerated atherosclerosis in prolonged maintenance hemodialysis. New. Engl. J. Med. 290:1974;697-701.
2. Ma K.W., Greene E.L., Raji L. Cardiovascular risk factors in the chronic renal failure and hemodialysis population. Am. J. Kidney. Dis. 19:1992;505-513.
3. Meng J., Sakata N., Takebayashi S., Asano T., Futata T., Araki N. et al. Advanced glycation end products of the Maillard reaction in aortic pepsin-insoluble and pepsin-soluble collagen from diabetic rats. Diabetes. 45:1996;1037-1043.
4. Arai K., Maguchi S., Fujii S., Ishibashi H., Oikawa K., Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycation sites. J. Biol. Chem. 262:1987;16969-16972.
5. Makita Z, Randoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosylation end products in patients with diabetic nephropathy. New Engl J Med 1991;836-42.
6. Makita Z., Bucala R., Rayfield R.J., Friedman E.A., Kaufman A.M., Korbet S.M. et al. Reactive glycosylation endproducts in diabetic uremia and treatment of renal failure. Lancet. 343:1994;1519-1522.
7. Sakata N., Meng J., Jimi S., Takebayashi S. Nonenzymatic glycation and extractability of collagen in human atherosclerotic plaques. Atherosclerosis. 116:1995;63-75.
8. Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S. et al. Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am. J. Pathol. 147:1995;654-667.
9. Pongor S., Ulrich P.C., Bencsath F.A., Cerami A. Aging of proteins: isolation and identification of a fluorescent chromophore from the reaction of polypeptides with glucose. Proc. Natl. Acad. Sci. USA. 81:1984;2684-2688.
10. Sell D.R., Monnier V.M. Structure elucidation of a senescence cross-link from human extracellular matrix. J. Biol. Chem. 264:1989;21597-21602.
11. Hayase F., Nagaraj R.H., Miyata S., Njoroge F.G., Monnier V.M. Aging of proteins: immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo. J. Biol. Chem. 263:1989;3758-3764.
12. Ahmed M.U., Thorpe S.R., Baynes J.W. Identification of N-(carboxymethyl)lysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261:1986;4889-4894.
13. Nakamura Y., Horii Y., Nishino T., Shiiki H., Sakaguchi Y., Kagoshima T. et al. Immunohistochemical localization of advanced glycosylation endproducts in coronary atheroma and cardiac tissue in diabetes mellitus. Am. J. Pathol. 143:1993;1649-1656.
14. Sakata N, Imanaga Y, Meng J, Tachikawa Y, Takabayashi S, Nagai R, Ikeda K, Horiuchi S. Immunohistochemical localization of different epitopes of advanced glycation end products in human atherosclerotic lesions. Atherosclerosis (in press).
15. Ross R. The pathogenesis of atherosclerosis, an update. New. Engl. J. Med. 314:1986;488-500.
16. London G.M., Drüeke T.B. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney. Int. 51:1997;1678-1695.
17. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes. 34:1985;938-941.
18. Vlassara H. Recent progress on the biologic and clinical significance of advanced glycosylation end products. J. Lab. Clin. Med. 124:1994;19-30.
19. Papanastasiou P., Grass L., Rodela H., Patrikarea A., Oreopoulos D., Diamandis E.P. Immunological quantification of advanced glycosylation end-products in the serum of patients on hemodialysis. Kidney. Int. 46:1994;216-222.
20. Hricik D.E., Schulak J.A., Sell D.R., Fogarty J.F., Monnier V.M. Effect of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney. Int. 43:1993;398-403.
21. Yamada K., Miyahara Y., Hamaguchi K., Nakayama M., Nakano H., Nozaki O. et al. Immunohistochemical study of human advanced glycosylation end-products (AGE) in chronic renal failure. Clin. Nephrol. 42:1994;354-361.
22. Wanner C., Zimmermann J., Quaschning T., Galle J. Inflammation, dyslipidemia and vascular risk factors in hemodialysis. Kidney. Int. 62:1997;S53-S55.
23. Palinsky W., Koschinsky T., Butler S.W., Miller E., Vlassara H., Cerami A., Witztum J.L. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Arterioscler. Thromb. Vasc. Biol. 15:1995;571-582.
24. Bucala R., Makita Z., Koschinsky T., Cerami A., Vlassara H. Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA. 90:1993;6434-6438.
25. Bucala R., Makita Z., Vega G., Grundy S., Koschinsky T., Cerami A. et al. Modification of low density lipoprotein by advanced glycosylation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. USA. 91:1993;9441-9445.
26. Requena J.R., Fu M.X., Ahmed M.U., Jenkins A.J., Lyons T.J., Thorpe S.R. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol. Dial. Transplant. 11(Suppl 5):1996;48-53.
27. Miyata T., Ueda Y., Shinzato T., Iida Y., Tanaka S., Kurokawa K. et al. Accumulation of albumin-linked and free-form pentosidine in the circulation of uremic patients with end-stage renal failure: renal implications in the pathophysiology of pentosidine. J. Am. Soc. Nephrol. 7:1996;1198-1206.